Corvus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2.87	8.74	12.62	13.16	63.46	16.46
Short-Term Investments	62.82	43.22	14.53	29.14	5.99	27.8
Cash & Short-Term Investments	65.69	51.96	27.15	42.3	69.45	44.26
Cash Growth	57.71%	91.40%	-35.82%	-39.09%	56.92%	-43.24%
Accounts Receivable	0.03	0.08	0.03	0.59	0.51	-
Other Receivables	0.31	0.14	0.04	0.05	0.03	0.09
Receivables	0.35	0.22	0.06	0.63	0.54	0.09
Prepaid Expenses	0.22	0.47	0.38	0.43	0.45	0.4
Other Current Assets	0.69	1.76	0.37	0.29	0.87	0.59
Total Current Assets	66.94	54.41	27.96	43.66	71.31	45.34
Property, Plant & Equipment	1.15	1.33	1.39	2.57	3.64	2.55
Long-Term Investments	11.53	12.54	16.12	21.88	34.27	37.23
Other Long-Term Assets	0.85	0.63	0.09	0.13	0.24	0.41
Total Assets	80.47	68.91	45.55	68.24	109.46	85.53
Accounts Payable	1.97	2.58	1.53	1.98	1.57	3.47
Accrued Expenses	5.16	3.44	3.73	7.39	6.96	7.42
Current Portion of Leases	0.38	0.19	1.37	1.23	1.05	1.08
Other Current Liabilities	0.57	29.2	0.25	0.16	0.12	0.18
Total Current Liabilities	8.07	35.4	6.87	10.75	9.69	12.15
Long-Term Leases	0.63	0.94	-	1.37	2.6	1.23
Total Liabilities	8.71	36.34	6.87	12.13	12.29	13.38
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	472.79	430.86	374.36	364.36	361.67	295.28
Retained Earnings	-399.97	-397.01	-334.72	-307.69	-266.38	-223.14
Comprehensive Income & Other	-1.06	-1.29	-0.97	-0.56	1.87	0
Total Common Equity	71.77	32.57	38.68	56.12	97.16	72.15
Shareholders' Equity	71.77	32.57	38.68	56.12	97.16	72.15
Total Liabilities & Equity	80.47	68.91	45.55	68.24	109.46	85.53
Total Debt	1.01	1.12	1.37	2.6	3.65	2.31
Net Cash (Debt)	64.68	50.84	25.78	39.7	65.8	41.95
Net Cash Growth	56.62%	97.25%	-35.08%	-39.67%	56.87%	-43.91%
Net Cash Per Share	0.86	0.83	0.54	0.85	1.57	1.42
Filing Date Shares Outstanding	74.68	68.14	49.04	46.57	46.55	38.31
Total Common Shares Outstanding	74.68	67.9	49.04	46.55	46.55	28.37
Working Capital	58.87	19.01	21.09	32.91	61.62	33.19
Book Value Per Share	0.96	0.48	0.79	1.21	2.09	2.54
Tangible Book Value	71.77	32.57	38.68	56.12	97.16	72.15
Tangible Book Value Per Share	0.96	0.48	0.79	1.21	2.09	2.54
Machinery	2.81	2.69	2.85	2.82	2.62	2.61
Leasehold Improvements	0.03	2.08	2.08	2.08	2.08	2.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.